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The phenomenological and, consequently, pathophysiological heterogeneity of schizo-
phrenia may be substantially decreased by determining etiologically valid subgroups. In 
a cross-sectional study, we analyzed the brain structural impairments of outpatients with 
schizophrenia using concurrent subgrouping methods, partly to enhance the extensity 
of exploration, and partly to estimate the validation of the divisions. High resolution 
T1-weighted MR images were obtained for 21 patients and 13 healthy controls. Localized 
gray matter volumetric deficits were defined with optimized voxel-based morphometry. 
Employing two concurrent methods (i.e., the widely known deficit-non-deficit division vs. 
the neurocognitive clusters we identified earlier) the patient group was iteratively divided 
into two subgroups, and their volumetric peculiarities were compared with one another 
and with healthy controls. Our division revealed more significant differences demonstrat-
ing bilateral brain structural deficits, which affected the association cortices, primarily 
the heteromodal fields and partly the unimodal fields. This is the first study that showed 
that abnormalities of the association cortices can be bihemispherial and expanded in 
schizophrenia, even in the cases of outpatients living integrated in society. Our result 
suggests that the extended association cortex abnormalities could constitute substantial 
and determining neurological substrates in the phenomenology and aetiopathogenesis 
of schizophrenia, at least in a subgroup of patients with more unfavorable neurocognitive 
characteristics.
Keywords: heterogeneity, subgroups, voxel-based morphometry, association cortex, heteromodal brain fields
inTrODUcTiOn
From a research point of view, schizophrenia is widely accepted as a heterogeneous illness. Allowing 
for heterogeneity, the obviously non-overlapping clinical, pathophysiological, and etiological diver-
sity can be substantially decreased by determining etiologically valid subgroups. Currently, only one 
division has a great impact, the division of deficit and non-deficit subgroups. The deficit syndrome has 
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been defined as a putative subtype of schizophrenia by Carpenter 
et al. (1). According to this definition, the syndrome is character-
ized by primary, idiopathic, and enduring negative symptoms 
that are also marked and present during clinically stable periods. 
According to the authors, this distinction is not only a reliable and 
valid construct but also results in categorically distinct subgroups 
(2). As with other psychiatric diagnostic categories, the diagnosis 
of deficit syndrome shows minor (but relevant) instability. This 
observation was highlighted by the Amador et al. (3) follow-up 
study of diagnostic validity. This study found that when using 
a repeated diagnostic process, many years later, the initial diag-
nosis was actually changed to its opposite in 17% of the cases 
in the deficit group and in 12% of the cases in the non-deficit 
group. Furthermore, Peralta and Cuesta (4), who studied the 
distribution of temporary vs. permanent negative symptoms, 
and primary vs. secondary negative symptoms in a mixed group 
of psychotic syndromes (including those outside the diagnostic 
category of schizophrenia), found that deficit syndrome was not 
specific to schizophrenia. Depending on the diagnostic method 
used, persistent primary symptoms associated with the clinical 
diagnosis of schizophrenia were present in 14–37% of the cases, 
while their occurrence was 2–22% in other non-schizophrenic 
psychoses.
Aiming to detect valid schizophrenia subgroups, a robust 
cross-sectional study was performed in Szeged, Hungary. The 
study included performing a systematic neuropsychological 
battery, assessing clinical symptoms, neurological soft signs, 
and morphogenetic anomalies, and measuring event-related 
potentials of 50 outpatients with schizophrenia in their compen-
sated states (5). An explorative fuzzy cluster analysis revealed 
two subgroups in this sample that could be distinguished from 
one another on symptomatologic, cognitive, and neurological 
levels. The analyses have demonstrated that cluster Z had more 
favorable characteristics, while cluster S had more unfavorable 
(more serious) characteristics. Importantly, these new clusters 
did not correspond to the deficit/non-deficit categories. In cluster 
Z (N =  27), 96.30% of the patients had non-deficit diagnoses, 
but in cluster S (N = 23) only 56.50% of the patients had deficit 
and 43.50% had non-deficit diagnoses. The differing patterns of 
detected cognitive dysfunctions and differences in the occurrence 
and the laterality of neurological developmental anomalies indi-
cate that there may be hemispherical differences between patients 
belonging to distinct clusters. We characterized cluster S as a 
subgroup of patients with schizophrenia with lower education 
and IQ, which probably reflect a pronounced cognitive disorder 
(5). Specifically, these patients showed serious impairment in 
working memory and executive tasks, including assessments 
of visual working memory, attentional set shifting and inhibi-
tory functions (5). Interestingly, the performance of cluster Z 
in these working memory and executive control tasks was not 
only significantly better than the performance of cluster S, but 
their performance was in the normal range of the population. In 
sum, patients belonging to cluster S showed a profound deficit 
in working memory and executive control functions, whereas 
the cognitive profile of cluster Z could be characterized with 
intact attentional and executive control functioning. Based on 
the analysis of the same patient population, we found less clear 
results with the deficit/non-deficit subgrouping method. The 
deficit and non-deficit subgroups did not differ significantly in 
tasks assessing working memory and inhibitory executive func-
tions and showed only subtle difference in attentional set-shifting 
function, possibly due to the heterogeneity of the cognitive profile 
of patients in the non-deficit subgroup (5).
The structural MRI can reveal brain volumetric differ-
ences that might be related to the potential neural substrates 
of schizophrenia or represent the consequences of the disease. 
Although a plethora of studies have investigated brain volumes 
in schizophrenia, few publications have examined the differ-
ences between patients with deficit and non-deficit syndromes. 
Considering this division, one study (6) reported larger lateral 
ventricles on the right side in non-deficit syndrome compared to 
deficit syndrome, but it found no difference in terms of frontal 
lobe volume. However, the ventricles were found larger in deficit 
syndrome patients, according to some other studies (7, 8). The 
results regarding gray matter (GM) volume are also contradic-
tory: non-deficit groups are reported to have less GM volume 
(9, 10), while other studies have found smaller GM volume in 
patients with deficit syndrome schizophrenia (11).
This study aimed to reveal the most brain structural anomalies 
in outpatients with schizophrenia, while concurrently using sub-
grouping methods for the patient group. The sample-population 
was composed of patients who had participated in the earlier 
cluster exploring study (5). In addition, the patients were in 
stable mental state at the time of this study, were cooperative, and 
were able to be matched to each other based on their age, gender, 
and clusters. The patient group was iteratively divided into two 
subgroups, and the brain volumetric peculiarities of the entire 
mixed group of patients and their subgroups were compared with 
the healthy controls and with one another in a cross-sectional 
study.
MaTerials anD MeThODs
subjects
Patients with schizophrenia (N =  21) were enrolled from the 
outpatient clinic of the Department of Psychiatry, University of 
Szeged. They were recruited from the previous cluster exploration 
study in which we explored cluster S and cluster Z; therefore, we 
knew the clusters for all the patients. Cluster Z had N = 10 patients, 
while cluster S had N = 11. Patients were diagnosed (DSM-IV-TR) 
(12) and clinically evaluated by an expert psychiatrist (István 
Szendi) using the Positive and Negative Syndrome Scale (PANSS) 
(13). The deficit and non-deficit diagnoses were made using The 
Schedule for the Deficit Syndrome (14); according to this meas-
urement, there were N = 13 patients in the non-deficit group and 
N = 8 patients in the deficit syndrome group. All patients with 
deficit syndrome belonged to the cluster S. The patients were all in 
a stable condition and currently taking antipsychotic medication. 
All substances [eight types of second generation antipsychotics 
(SGA), one depot first generation antipsychotic, and one first 
plus second generation combination] were usually prescribed in 
moderate doses, according to the medication protocols; the mean 
dose in chlorpromazine equivalence was 282 ± 166 mg/die.
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Control subjects were recruited from hospital staff and 
community volunteers. They were evaluated with a modified 
structured interview (Mini International Neuropsychiatric 
Interview) (15, 16). Control participants with a personal his-
tory of psychiatric disorder or a family history of psychotic and 
affective spectrum disorders, history of neurological illness, any 
medical illness known to affect brain structure, head injury with 
loss of consciousness for more than 30 min, clinically significant 
substance abuse within the last 6 months, or any medical illness 
that could significantly constrain neurocognitive functions were 
excluded. All participants were 18–50 years of age, with a mini-
mum of 8 years of education (primary school), and able to give 
informed consent.
image acquisition and Voxel-Based 
Morphometry (VBM)
Imaging was performed using a 1.5-T General Electric Signa 
Excite scanner at the Department of Radiology, University of 
Szeged, Hungary. High resolution T1-weighted images (3D 
IR-FSPGR, TR/TE/TI: 10.3/4.2/450 ms, flip angle: 15°, ASSET: 2, 
FOV: 25 cm × 25 cm, matrix: 256 × 256, slice thickness: 1 mm) 
were acquired.
We employed an “optimized” VBM-style protocol (17, 18) 
using FSL (19). Non-brain parts were removed from all structural 
images (20), and tissue-type segmentation was performed using 
FAST4 (21). The resulting gray-matter partial volume images 
were registered to a standard space (MNI152) using linear 
transformation (22), followed by a non-linear registration (23). 
The resulting images were averaged to create a study-specific 
template, to which the native GM images were then non-linearly 
re-registered. The registered partial volume images were then 
modulated (to correct for local expansion or contraction) by 
dividing by the Jacobian of the warp field. The modulated 
segmented images were smoothed with an isotropic Gaussian 
kernel, with a sigma of 3 mm. Finally, a voxel-wise general linear 
model was applied, using permutation-based non-parametric 
testing. The model encoded group membership. The following 
comparisons were carried out: patients vs. controls, deficit vs. 
non-deficit syndrome patients, Z vs. S cluster, and all subgroups 
vs. controls in separate analyses. Thresholding was performed 
using a novel method, the threshold-free cluster enhancing 
technique (24). Images were thresholded at p < 0.05 and cor-
rected for multiple comparisons as implemented in FSL.
statistics on the Demographic and clinical 
Variables
The statistical analysis of the demographic variables and the 
PANSS scores was performed using SPSS version 20 for Windows 
(released 2011, IBM Corp., Armonk, NY, USA). Years in educa-
tion, IQ, age, duration of illness, and PANSS scores were com-
pared by means of the non-parametric Mann–Whitney test. In 
the results section, Bonferroni-corrected p values were reported, 
although effect sizes were more pronounced as a result of the 
small sample size and high type two error rate. R values were 
calculated as indices of effect size.
resUlTs
Demographics and clinical Measures
Regarding the demographic variables, there was no signifi-
cant difference between the healthy controls and the entire 
patient group or the different divisions of schizophrenia in 
terms of age, IQ (Wechsler Adult Intelligence Scale), and 
years of education. The duration of illness was similar in the 
schizophrenia groups. The PANSS scores indicated different 
clinical states at the time of the study. Cluster Z scored lower 
on the negative symptom subscale (Mann–Whitney U = 10, 
Z =  3.18, p =  0.01; r =  0.69) compared to cluster S. In the 
other classification, the non-deficit group scored lower on 
the negative (Mann–Whitney U =  6.5, Z =  3.31, p =  0.02; 
r = 0.72) and the general (Mann–Whitney U = 7.5, Z = 3.23, 
p = 0.02; r = 0.7) subscales, and they had lower total scores 
(Mann–Whitney U =  5, Z =  3.41, p =  0.01; r =  0.74) than 
the deficit syndrome patients. For exact data, see Table  1. 
We converted all antipsychotic doses to chlorpromazine 
equivalents using published equivalencies for conventional 
and atypical antipsychotics. No differences were found in the 
medication between the clusters or deficit and non-deficit 
groups.
gM Volume alterations in subjects with 
schizophrenia
In this study, differences in brain structure between the healthy 
persons and the more favorable (the non-deficit and the cluster 
Z) subgroups of patients could not be detected (p > 0.2, cor-
rected for multiple comparisons). In the same way, the differ-
ences between the more favorable and the more unfavorable 
(the deficit and the cluster S) subgroups of patients were 
not statistically remarkable (p >  0.2, corrected for multiple 
comparisons).
In addition to the whole group, the differences between the 
unfavorable subgroups of patients and the healthy controls reached 
the level of significance. In the cases of patients who belonged to 
either or both of the subgroups with more unfavorable natures 
(the deficit group and cluster S), there were verified notable brain 
structural differences compared to the healthy controls. Most of 
the relevant areas were revealed in the analysis between cluster S 
and the healthy controls.
Schizophrenia Group vs. Healthy Controls
The whole mixed group of patients with schizophrenia was 
measured to have lower GM volumes in the left insular cortex 
and left inferior frontal gyrus compared to the healthy con-
trols (p <  0.036, corrected for multiple comparisons, Table  2; 
Figure 1—row A).
Deficit-Syndrome vs. Healthy Controls
The deficit group showed lower cortical GM volumes in the 
bilateral perisylvian area, in the right orbitofrontal cortex and in 
the inferior and polar areas of the left frontal cortex (p < 0.05, 
FigUre 1 | Significant gray matter deficits in schizophrenia patients. Row  
(a) the whole, mixed group of patients with schizophrenia compared to the 
healthy controls. Row (B) the deficit group compared to the healthy controls. 
Row (c) the cluster S compared to the healthy controls. Red-to-yellow 
volumetric clusters indicate p values between 0.05 and 1, corrected for 
multiple comparisons. In all three comparisons, the same slices are 
presented at z-coordinates indicated at the bottom of the figure.
TaBle 2 | Significant volumetric clusters of gray matter volume deficits in the 
group of patients with schizophrenia compared to the healthy controls.
lobe region side size 
(voxels)
pmax x 
(mm)
y 
(mm)
z 
(mm)
Frontal Inferior frontal gyrus L 25 0.034 −54 12 14
Insula Insular cortex L 199 0.024 −40 12 8
Insular cortex L 77 0.026 −36 −16 20
Insular cortex L 23 0.036 −30 22 −8
L, left.
The cluster sizes are indicated in voxels in standard space (voxel size: 2 mm3 isotropic). 
The maximal p-value is reported in the fifth column. Peak p-value coordinates are 
reported in the MNI152 standard space. There were three partly separable volumetric 
clusters detected in the area of the left insular cortex.
TaBle 1 | Demographic and clinical characteristics of the study groups.
healthy control subjects with schizophrenia
cluster Deficit syndrome
schizophrenia 
group Total
S Z Deficit non-
deficit
Median Median r Median Median r Median Median r
Education in years 12 11 0.25 10 12 0.56 9.5 12 0.47
IQ (Wechsler Adult Intelligence Scale) 108 99 0.38 92 103 0.61 89.5 103 0.65
Age 34 39 0.14 41 37 0.08 34 44 0.35
Duration of illness 15 13 0.15 13 15 0.13
PANSS-P 10 8.5 0.23 17.5 8 0.43
PANSS-N*,# 21 11 0.69 27.5 13 0.72
PANSS-G# 39 20.5 0.56 43.5 21 0.70
PANSS-T# 75 40.5 0.61 83.5 45 0.74
Gender n % n % n % n % n % n %
Male 6 46.2 11 52.4 6 54.5 5 50 6 75 5 38.5
Female 7 53.8 10 47.6 5 45.5 5 50 2 25 8 61.5
*Significant difference (p < 0.05) between clusters.
#Significant difference (p < 0.05) between the deficit and non-deficit groups.
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non-deficit vs. cluster S and Z), we divided the patient group 
into two subgroups, and structural imaging markers of these 
subgroups were compared with one another and with the healthy 
controls. Our results demonstrated the heterogeneity of the 
group of patients diagnosed with schizophrenia (according to 
the DSM-IV) who were treated in outpatient care, on the one 
hand, and the advantages of the subgrouping method in revealing 
brain structural anomalies on the other hand. Both subgroup-
ing method uncovered more differences than the comparison 
between the whole patient group and the healthy control group.
Based on our results, the brain volumetric impairments 
characterizing the patients most generally were the volumetric 
corrected for multiple comparisons, Table 3; Figure 1—row B) 
compared to the normal controls.
S-Cluster vs. Healthy Controls
Voxel-based morphometry analysis indicated lower cortical GM 
volumes in the cluster S patients compared to the normal controls 
in the bilateral insula, bilateral orbitofrontal cortex, left superior 
temporal sulcus, right anterior cingulate gyrus, bilateral subcal-
losal region, and left inferior frontal sulcus and gyrus (the latter 
is the opercular part of the dorsal premotor cortex) (p < 0.047, 
corrected for multiple comparisons, Table 4; Figure 1—row C). 
Notably, the differences were more extensive than in the mixed 
group of patients or in the deficit subgroup.
DiscUssiOn
In the present cross-sectional study, we compared the brain 
volumetric characteristics of a mixed group of patients with 
schizophrenia to the structural relations of the healthy con-
trols. Furthermore, using two concurrent methods (deficit and 
TaBle 4 | Significant volumetric clusters of gray matter volume deficits in the 
cluster S patients compared to the healthy controls.
lobe region side size 
(voxels)
pmax x 
(mm)
y 
(mm)
z 
(mm)
Frontal Frontal pole L 302 0.011 −18 60 −8
Inferior frontal 
sulcus
L 424 0.002 −42 6 26
Inferior frontal 
gyrus
L 225 0.001 −54 12 12
Orbitofrontal cortex L 459 0.009 −34 34 −6
Orbitofrontal cortex L 352 0.014 −16 32 −20
Orbitofrontal cortex R 364 0.014 20 26 −14
Orbitofrontal cortex R 27 0.041 26 38 −10
Temporal Superior temporal 
sulcus (planum 
temporale)
L 147 0.029 −44 0 −20
Insula Insular cortex L 2,774 0.003 −42 −12 16
Insular cortex R 2,714 0.014 34 −4 −2
Medial 
paralimbic 
cortices
Anterior cingulate 
cortex
R 63 0.042 14 48 8
Subcallosal cortex L + R 818 0.023 −2 24 −8
L, left; R, right.
The cluster sizes are indicated in voxels in standard space (voxel size: 2 mm3 isotropic). 
The maximal p-value is reported in the fifth column. Peak p-value coordinates are 
reported in the MNI152 standard space. There were two partly separable volumetric 
clusters detected in the area of the orbitofrontal cortices on both sides. The affected 
areas of the perisylvian cortex on the right side seemed to be extending partly to the 
parietal lobe (onto the operculum and supramarginal gyrus), beside this the temporal 
deficits migrate lightly onto the parahippocampal areas.
TaBle 3 | Significant volumetric clusters of gray matter volume deficits in the 
group of patients with deficit syndrome compared to the healthy controls.
lobe region side size 
(voxels)
pmax x 
(mm)
y 
(mm)
z 
(mm)
Frontal Frontal pole L 114 0.029 −44 44 −8
Inferior frontal sulcus L 18 0.039 −36 42 8
Orbitofrontal cortex R 16 0.037 20 28 −16
Orbitofrontal cortex R 9 0.04 26 38 −8
Insula Insular cortex L 43 0.03 −40 −12 18
Insular cortex L 3 0.049 −38 −18 12
Insular cortex L 2 0.049 −34 12 12
Insular cortex R 37 0.032 28 22 −4
Insular cortex R 1 0.05 36 24 0
L, left; R, right.
The cluster sizes are indicated in voxels in standard space (voxel size: 2 mm3 isotropic). 
The maximal p-value is reported in the fifth column. The peak p-value coordinates are 
reported in the MNI152 standard space. There were two partly separable volumetric 
clusters detected in the area of the right orbitofrontal cortex, as well as, three left 
volumetric clusters and two in the right insular cortex.
FigUre 2 | A graphical abstract of the volumetric impairments. The figure 
shows which cortical structures were affected in the different comparisons. 
The neuroradiological units are presented according to the work of 
Rademacher and colleagues (25). Alterations detected even on the level of 
the whole mixed group of patients (related to the healthy controls) are 
marked in yellow, green color marks alterations detected on the level of the 
deficit subgroup, and the anomalies detectable exclusively in the cluster S 
are marked in blue.
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decrease of the inferior frontal gyrus and the insular cortex (both 
in the left hemisphere). These two volumetric deficits were observ-
able in the whole mixed group of outpatients with schizophrenia; 
at the same time, these anomalies also appeared in the two 
unfavorable subgroups (in the deficit subgroup and in cluster S). 
In the subgroup of patients with deficit syndrome, in addition to 
the alterations in the whole group, volumetric decreases of the 
left frontopolar and right orbitofrontal cortices were detected and 
were accompanied by alterations of the insular cortices in both 
hemispheres. The latter anomalies were also pinpointed in the 
cluster S. Compared with healthy controls, the most expanded 
brain structural alterations were detected for cluster S patients. 
In addition to those anomalies that were also observed for the 
whole patient group and the deficit subgroup, there were volu-
metric deficits in the left orbitofrontal cortex, a decrease of GM 
volumes of the left planum temporale, right anterior cingulate 
cortex and of the bilateral subcallosal cortices. The perisylvian 
volumetric decrease on the right side expanded to the parietal 
lobe (onto the operculum and supramarginal gyrus), whereas the 
temporal impairment spread lightly onto the parahippocampal 
areas (Figure 2).
Based on the functional anatomy of these areas, the frontal 
pole and the orbitofrontal cortex belong to the frontal het-
eromodal association cortices. The inferior frontal gyrus and 
sulcus also partly belong to this area, and partly to the frontal 
motoric association cortex. The left planum temporale is a part 
of the auditory association cortex. The insula is a constituent of 
the paralimbic olfactocentric heteromodal association cortex. 
The anterior cingulum, subcallosal cortex, and parahippocampal 
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gyrus belong equally to the paralimbic hippocampocentric 
association cortex. The supramarginal gyrus along with the 
parietal operculum is parts of the parietal heteromodal associa-
tion cortex, and the latter participates in the constitution of the 
auditory and somatosensory association cortices as well. For 
details concerning the relationship of the affected regions and the 
association cortices mentioned in this paragraph, see the work of 
Rademacher et al. (25).
We can draw two conclusions from our results. First, 
although the involvement of association cortices could specifi-
cally differentiate the unfavorable subgroup of patients from the 
healthy controls, there could be no anomalies in the primary 
cortices. Second, the volumetric deficit in the association cortices 
(primarily heteromodal and to a lesser degree, unimodal) could 
be extended and could affect both hemispheres.
Although heteromodal cortex anomalies have often been 
theoretically associated with the aetiopathogenesis of the illness, 
this extent of involvement, to our knowledge, has never been 
detected. Through targeted examination of three heteromodal 
areas (prefrontal, inferior parietal, and superior temporal) in a 
mixed group of patients with schizophrenia and schizoaffective 
disorders, Buchanan’s team observed (26) volumetric decreases 
of the inferior prefrontal region and reversal of normal asym-
metry in the inferior parietal cortex. In addition, few studies have 
empirically examined the supposed involvement of more than 
one heteromodal cortical association region as neuroanatomical 
substrates of the illness (27–29), moreover, with contradictory 
results. For instance, in one study, the volumes of the frontal 
and the superior temporal gyri were more strongly correlated 
in healthy persons (28), whereas another study found that the 
inferior parietal regions correlated with the prefrontal areas 
in patients but not in healthy persons (29). It is plausible that 
applying mixed, undifferentiated, heterogenic phenotypes could 
result in contradictory and ill-replicable results. Our results also 
suggest that targeted examination of association fields, with the 
help of neurocognitive subgrouping, could be promising in the 
explorative study of the aetiopathogenesis of schizophrenia.
The non-targeted, un-biased, data-driven VBM method 
allows examination of the whole cortical GM. VBM studies in 
schizophrenia have been frequently reported since the mid-1990s 
along with meta-analyses aimed at synthetizing and interpreting 
the data in the scientific literature of the field. One research 
group that builds analyses systematically focuses on brain 
structural alterations related to the genetic liability to psychosis 
and schizophrenia (30–33). Others deal narrowly with schizo-
phrenia in comparisons between patients and healthy controls, 
or patients who experienced only one episode and those whose 
illnesses are chronic, or patients with schizophrenia and bipolar 
disorder (34–38). Besides, significant meta-analyses have pointed 
at the determining roles of gender (39) and laterality (40) in this 
research area.
The volumetric decreases of the left inferior frontal gyrus 
and insula, detected by our study in the whole, mixed group of 
patients with disease duration of 16 ±  7  years, are among the 
most frequently-reported VBM findings associated with the 
clinical expression of schizophrenia (37). Gray matter reduc-
tions of the left or bilateral insula were also observed in groups 
of patients with first-episode and chronic schizophrenia as well 
(34, 35). Moreover, these differences were revealed after the first 
psychotic episode in the broader, mixed samples of patients 
with psychotic disorders (32). Baseline volumetric decrease of the 
inferior frontal gyrus was also observed in high-risk subjects who 
later developed an established psychotic episode (30). Unlike 
in the case of clinical expression, no association with genetic 
diathesis was identified by a meta-analysis targeted at revealing 
VBM correlations of clinical manifestation and genetic liability 
(37). However, other meta-analyses could find correspondences 
volumetric decrease of the right insula relative to controls was 
detected in the group of first- or second-degree relatives of 
schizophrenic patients, qualified as a high-risk population by 
certain symptomatic signs or definite alteration of a genetic 
polymorphism (36). GM reduction of the left inferior frontal 
gyrus (associated with functional imaging hyperactivity) has 
also showed a connection to familial high risk for psychosis in a 
multimodal meta-analysis (33).
Bilateral volumetric reduction of the parahippocampal gyrus 
has also been consequently detected in the VBM meta-analyses 
and is suggested to be correlated to the genetic diathesis of 
schizophrenia (37). Moreover, reduction of volume of the PHG 
on the left side was associated with a genetic liability generally to 
psychosis (32), and the left-side decrease was also found by two 
meta-analyses comparing patients to controls (35, 40). Similarly, 
bilateral volumetric reductions of the anterior cingulum were 
found to correlate to genetic liability to schizophrenia (36) and 
more broadly to psychosis (32). Bilateral anterior cingulum 
reductions were also observable in studies comparing patients 
to controls (34, 35, 40). Additionally, an inverted laterality pat-
tern was revealed in a targeted meta-analysis by Crow et al. (40) 
comparing patients with schizophrenia and bipolar disorder. GM 
reductions of the right anterior cingulum and left insula (and 
parahippocampal gyrus) were characteristic of schizophrenic 
samples, whereas the opposite pattern, volumetric decreases 
of the left anterior cingulum and right insula were observed in 
bipolar groups.
Interestingly, our neurocognitive subgrouping method has 
revealed some other GM volumetric alterations which have not 
emerged in earlier meta-analyses. All of them are considered 
parts of heteromodal association fields: the bilateral subcallosal 
and orbitofrontal cortices, the left frontal pole and planum 
temporale, and the right supramargynal gyrus and parietal 
operculum. Besides the above mentioned ROI studies [e.g., Ref. 
(26)], a VBM meta-analysis also suggested specific impairment 
of multimodal brain regions (37), assumingly with supervisory 
functions and with a determining role in the development of 
clinical manifestation, i.e., the impairment of the neural basis of 
the cognitive control system, which is one of the cognitive func-
tions most-affected in this illness (41–43).
In the light of the VBM meta-analyses, our results can draw 
attention to one more relevant aspect: according to our results, in 
the case of chronic schizophrenia, the widespread cortical (34) 
and progressive cortico-striato-thalamic (36) GM decreases are 
not characteristic of all patients. They might play a pathogenetic 
role only in the subgroup of patients with more unfavorable 
neurocognitive capacities.
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In summary, here we found that a cognitively unfavorable 
subgroup of patients with schizophrenia was characterized by 
an expanded, bilateral brain structural anomaly that affects the 
heteromodal and unimodal association cortices. This extent of 
distributed cortical volume deficit, which is specifically attached 
to the association areas, has not been detected in schizophrenia 
earlier. Note that patients belonging to this subgroup are living 
integrated into society, and are treated in outpatient care, that is, 
they do not belong to a particular ill sub-population.
Importantly, following the division of deficit/non-deficit 
syndrome, some patients with non-deficit syndrome also turned 
out to belong to this cognitively unfavorable subgroup (cluster S). 
Moreover, it is a surprising result that cluster S, which merged 
patients living with endurable primary negative symptoms 
(regarded as the most serious cases) with certain patients 
without deficit characteristics, revealed a larger magnitude of 
brain structural anomalies compared with the group of deficit 
syndrome. This result might show that in the case of patients 
with schizophrenia living integrated in the society the presence 
or absence of enduring, primary negative symptoms is not a solely 
etiologically relevant feature. It seems that the pattern of vari-
ables showing neurocognitive impairment can also be essential 
in revealing much more extended brain structural differences in 
the same pool of patients.
This result also indicates that in the case of patients without 
primary negative symptoms, pronounced cognitive and brain 
structural disorders are also crucial in revealing functional sub-
groups of this illness. Thus, in terms of neurocognitive deficits, a 
significant number of patients without deficit syndrome might 
be more closely related to patients with deficit syndrome than to 
other non-deficit patients with better neurocognitive functions. 
That is, according to our results, the subgroup of patients without 
deficit syndrome is fundamentally heterogeneous. Instead of 
assuming the primacy of the primary negative symptoms, the 
structural manifestation of the neurocognitive disorders appears 
to be more relevant.
This study has some limitations. Beyond the general difficul-
ties of performing structural MRI investigations of patients with 
schizophrenia, where the observable volumetric deficit may be 
close to the limit of detection for MRI (44, 45), the number of 
subjects can also limit our results; a larger patient cohort might 
improve the reliability of the results. The sample-population 
was composed of patients who had participated in the earlier 
cluster-exploring study (5) for placement into clusters. In addi-
tion, the patients had to be in a stable mental state at the time 
of this study, had to be cooperative, and had to be able to be 
matched to each other based on their age, gender, and clusters. 
This was the barrier which determined that we could not enroll 
more patients. Another potential limitation is that external and/
or repeated validation of the existence of our subdivision of 
patients to clusters S and Z using robust systematic neurocogni-
tive mapping is unavailable for the time being. Furthermore, in 
addition to the genetic heterogeneity, the treatment heterogene-
ity of patient populations (46) must be considered. Moreover, 
for the time being, we cannot establish a clear understanding 
of the influences that are exerted on brain structural alterations 
by the chronic use of antipsychotics in schizophrenia. Some 
meta-analyses suggest that we should take these influences into 
account [e.g., Ref. (47, 48)]; however, it is not clear enough what 
the extent of these impacts is, what kind of regional or agent- or 
duration-dependent peculiarities they have, and how all of these 
can be manifested on the bases of the individual dynamics of the 
progression of structural changes in the brain. The heterogene-
ity of the disorder makes our clairvoyance in this area difficult 
as well. Because this illness is also heterogeneous regarding 
the progression of structural changes in the brain (49, 50), the 
influence of persistent therapy cannot be evaluated clearly on the 
basis of studies executed on samples of mixed patient groups. It 
is not surprising that a systematic review could not find a linear 
relationship between the degree of antipsychotic exposure and 
progressive structural changes in the brain (51). Furthermore, 
specific pharmacological agents and types of agents can exert 
different influences in this area. It seems that applying first-
generation antipsychotics (FGA) is associated with more unfa-
vorable consequences: according to the results of a meta-analysis 
based on longitudinal studies, patients treated with at least one 
FGA higher-mean daily antipsychotic dose correlated with more 
progressive GM loss, while in patients treated only with SGA 
less progressive GM loss was detected in the case of higher daily 
doses (52). A meta-analysis detected brain regional differences 
related to treatment: in four areas a relative volumetric decrease 
appeared, while in three areas a volumetric increase was observ-
able (53). Among these, only the volumetric decrease of the left 
inferior frontal gyrus occurred in our study as well; there were no 
other overlaps with the other regions. Considering the number of 
aspects needed to evaluate that in this study, in the subgrouping 
divisions, the CPZ equivalent doses of the antipsychotic therapy 
applied at the time of examinations did not correlate with the 
cross-sectional brain structural differences.
Clarifying the phenotype of schizophrenia is a relevant and 
urgent step in revealing the etiology of the illness. Defining 
subgroups through a theoretically robust and complex set of 
neurocognitive variables could help to detect more alterations 
than examining mixed groups or symptomatic subgroups of 
patients determined only by clinical phenomena and diagnoses. 
Based on the results of this brain structural study, we can suggest 
several hypotheses. The neurocognitive subgrouping method 
devised by us earlier (cluster S and Z) seems to be a more rel-
evant dividing method than the deficit-non-deficit separation. 
The subgroup of patients without deficit syndrome seems to 
be fundamentally not homogeneous. In the more unfavorable 
neurocognitive subgroup of patients (cluster S), an expanded 
bilateral brain structural impairment could be detected through 
volumetric analysis that primarily affects the heteromodal 
association cortices. This is the first study that showed that 
abnormalities of association cortices can be bihemispherial and 
expanded in schizophrenia, even in the cases of outpatients 
living integrated in society. The extensive abnormalities of the 
association cortices could constitute a peculiar, substantial and 
determining neurological substrate in the phenomenology 
and aetiopathogenesis of schizophrenia, at least concerning a 
subgroup of patients with more unfavorable neurocognitive 
characteristics. Targeted examination of association fields in 
neurocognitive subdivision seems to be promising.
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